The London COPD Exacerbation Cohort
Recruiting · NCT02755974 · Observational (researchers observe without assigning treatment) · Lead sponsor: Imperial College London
View the official record on ClinicalTrials.gov →What this trial is about
The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.
Who can take part
Age range
40 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Forced Expiratory Volume in 1 sec (FEV1)/Forced Vital Capacity (FVC) ratio of \<0.70
- Able and willing to give informed and written consent
Exclusion criteria
- Patients with a history of asthma, bronchiectasis, carcinoma of the bronchus, or other significant respiratory disease were excluded.
- Patients on Immunosuppressive medications or with active cancer
- Long term steroid therapy
- Age \<40 years at recruitment
Where it is running
1 location listed.
- National Heart and Lung Institute, Imperial College - London, United Kingdom